| Search by tag or site | Login to my blog ? Start my own blog |
 |
BioHealth InvestorBioHealth Investor (BHI) is a blog and journal focused on providing updated commentary and financial news from the biotech and medical technology industry. BHI's content is featured on Yahoo!Finance, Google Finance, TheStreet.com, SeekingAlpha.com and many other blogs and websites. BHI is also a proud member of The Business of Biotech Network, and the Investors Blog Network. |
Biowatch Alert: Exegenics Jumps 10% On Strong Volume, No News!
Posted on 11/02/2007 11:58:00 | Link | Post Comment
by H.S. Ayoub
BioHealthInvestor.com
Shares of eXegenics Corporation (EXEG.OB) gained almost 10% on Wednesday as volume more than tripled the 3 month daily average.
There were no significant news releases or other significant events that could be detected.
I featured eXegenics recently. The empty shell company was bought out by Dr.Phillip Frost, founder of Ivax Corp., and quickly announced that the company will be merging with two optical health biotech firms and renamed Opko Corporation. Opko will file for listing on the AMEX soon.
Two weeks ago, J&J Development Corp., a division of Johnson & Johnson (JNJ), took a substantial position in eXegenics according to the SEC filing.
The $146 million company has $8.6 million in cash and no debt according to the latest Yahoo! financial data. The company has not conducted any operations in some time, and will not do so until the merger is finalized, and the company begins operating under the new name Opko.
Shares of eXegenics closed at $4.02, just under the 52-week high of $4.10.
eXegenics has made BHI's BioWatch Alert List, and will be tracked for the next two weeks.
Source: BioHealthInvestor.com
_____________________
BioHealthInvestor.com
Shares of eXegenics Corporation (EXEG.OB) gained almost 10% on Wednesday as volume more than tripled the 3 month daily average.
There were no significant news releases or other significant events that could be detected.
I featured eXegenics recently. The empty shell company was bought out by Dr.Phillip Frost, founder of Ivax Corp., and quickly announced that the company will be merging with two optical health biotech firms and renamed Opko Corporation. Opko will file for listing on the AMEX soon.
Two weeks ago, J&J Development Corp., a division of Johnson & Johnson (JNJ), took a substantial position in eXegenics according to the SEC filing.
The $146 million company has $8.6 million in cash and no debt according to the latest Yahoo! financial data. The company has not conducted any operations in some time, and will not do so until the merger is finalized, and the company begins operating under the new name Opko.
Shares of eXegenics closed at $4.02, just under the 52-week high of $4.10.
eXegenics has made BHI's BioWatch Alert List, and will be tracked for the next two weeks.
Source: BioHealthInvestor.com
_____________________
- Mri To Lead Growth In Medical-imaging Market
- Malaria And Hiv - Eradication And Treatment
- Dragon’s New Production Process To Cut Costs
- Mrsa Update: Cepheid, Basilea And Nektar
- If Only Us Health Care Could Be More Like The Patriots (or Even The Red Sox) And Less Like The Yankees
- The Boston Condo Blog
- The Boston Real Estate Blog
- Biiwii.com Notes
- Millionaire Now! by Larry Nusbaum
- Newmark's Door
- Ludwig von Mises Institute
Examples
Morpheus Trading - Tue Sep 02, 2008 05:21AM
NOTE: Please click on the charts below to enlarge them [read more]
NOTE: Please click on the charts below to enlarge them [read more]
Morpheus Trading - Thu Sep 04, 2008 04:34AM
NOTE: Please click on the charts below to enlarge them if [read more]
NOTE: Please click on the charts below to enlarge them if [read more]
Morpheus Trading - Wed Sep 03, 2008 04:35AM
NOTE: Please click on the charts below to enlarge them [read more]
NOTE: Please click on the charts below to enlarge them [read more]
<< My Home | TheMoneyBlogs Home